ALEVE- naproxen sodium tablet 
Bayer HealthCare LLC.

----------

Aleve ® Tablets UI 1600169

Drug Facts

Active ingredient (in each tablet)

Naproxen sodium 220 mg (naproxen 200 mg) (NSAID) 1


1
nonsteroidal anti-inflammatory drug

Purposes

Pain reliever/fever reducer

Uses

Directions

  • Adults and children 12 years and older
  • take 1 tablet every 8 to 12 hours while symptoms last
  • for the first dose you may take 2 tablets within the first hour
  • do not exceed 2 tablets in any 8- to 12-hour period
  • do not exceed 3 tablets in a 24-hour period
  • Children under 12 years
  • ask a doctor

Other information

Inactive ingredients

FD&C blue #2 lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, titanium dioxide

Questions or comments?

1-800-395-0689 (Mon-Fri 9AM – 5PM EST)

Dist. by:
Bayer HealthCare LLC
Whippany, NJ 07981

In case of overdose, get medical help or contact a Poison Control Center right away.

PRINCIPAL DISPLAY PANEL - 24 Tablet Bottle Carton

Aleve Tablets - 24 Count CartonALL DAY STRONG®

ALEVE®

naproxen sodium tablets, 220 mg (NSAID)

Pain reliever/fever reducer

STRENGTH TO LAST 12 HOURS

ACTUAL SIZE
24 TABLETS

ALEVE 
naproxen sodium tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0280-6010
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NAPROXEN SODIUM (UNII: 9TN87S3A3C) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN SODIUM220 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POVIDONE (UNII: FZ989GH94E)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
Product Characteristics
Colorblue (light blue) Scoreno score
ShapeROUNDSize8mm
FlavorImprint Code ALEVE
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0280-6010-241 in 1 CARTON07/26/2002
124 in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:0280-6010-501 in 1 CARTON07/26/2002
250 in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:0280-6010-011 in 1 CARTON07/26/2002
3100 in 1 BOTTLE; Type 0: Not a Combination Product
4NDC:0280-6010-021 in 1 CARTON07/26/2002
4130 in 1 BOTTLE; Type 0: Not a Combination Product
5NDC:0280-6010-031 in 1 CARTON07/26/2002
5150 in 1 BOTTLE; Type 0: Not a Combination Product
6NDC:0280-6010-041 in 1 CARTON07/26/2002
636 in 1 BOTTLE; Type 0: Not a Combination Product
7NDC:0280-6010-06225 in 1 BOTTLE; Type 0: Not a Combination Product07/26/2002
8NDC:0280-6010-051 in 1 CARTON07/26/2002
865 in 1 BOTTLE; Type 0: Not a Combination Product
9NDC:0280-6010-07270 in 1 BOTTLE; Type 0: Not a Combination Product07/26/2002
10NDC:0280-6010-0990 in 1 BOTTLE; Type 0: Not a Combination Product07/26/2002
11NDC:0280-6010-101 in 1 TRAY07/26/2002
1110 in 1 BOTTLE; Type 0: Not a Combination Product
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02020407/26/2002
Labeler - Bayer HealthCare LLC. (112117283)

Revised: 8/2023
Document Id: 033526a5-1d79-3e78-e063-6394a90a2160
Set id: 00ef5b30-71d0-4cb4-84a3-48c67d1cea2a
Version: 17
Effective Time: 20230818
 
Bayer HealthCare LLC.